Portfolio company
Phylo
United States · £10.3m raised
Raised
£10.3m
Latest stage
Seed
Rounds recorded
1
Backed by
2 investors
Sectors
About
This company develops artificial intelligence agents and integrated software environments for researchers and life sciences organisations to automate biomedical research tasks.
SourceFunding history · 1
Similar companies
ScienceMachine
This company develops autonomous artificial intelligence agents to automate biomedical data analysis and research workflows for biotechnology and pharmaceutical organisations.
Capsule AI
This company develops autonomous agent systems that conduct scientific research and strategic analysis for pharmaceutical and biotechnology organisations.
Aneta
This company develops artificial intelligence agents to automate research workflows and laboratory tool operations for scientists and biotechnology researchers.
Cypher AI
This company provides a platform for recording experiments, tracking samples, and running bioinformatics pipelines for life science research and development laboratories.
Autopoiesis
The company develops an artificial intelligence research partner that performs autonomous scientific discovery for researchers at academic institutions and pharmaceutical companies.
Ingenix
This company develops an artificial intelligence system that integrates biological data to support drug development decisions for pharmaceutical and biotechnology organisations.
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
Kiin Bio
This company develops an artificial intelligence platform of virtual scientists to automate and coordinate drug discovery workflows for biotechnology firms and academic researchers.
